Search research articles
Contact Us
Filters
Showing results (41-50 of 355) with videos related to
Page
of 36
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
March 9, 2011
Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis
M Carrier, M A Rodger, P S Wells, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 2, 2012
Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients
K Gauthier, M J Kovacs, P S Wells, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 7, 2005
The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients
E Al-Yaseen, P S Wells, J Anderson, et al.
Thrombosis and Haemostasis
|
March 30, 2000
Outpatient treatment of pulmonary embolism with dalteparin
M J Kovacs, D Anderson, B Morrow, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
December 3, 1998
Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis
M Rodger, C Bredeson, P S Wells, et al.
Lancet (London, England)
|
May 21, 1998
SimpliRED D-dimer can reduce the diagnostic tests in suspected deep vein thrombosis
P S Wells, D R Anderson, J Bormanis, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 31, 2009
Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
G Le Gal, M Carrier, S Tierney, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 26, 2010
Incidence and clinical outcomes of occult cancers detected by computed tomographic pulmonary angiography in patients with acute pulmonary embolism
A Y-H Shen, G Le Gal, C Dennie, et al.
Thrombosis Research
|
May 11, 2016
PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease
P S Wells, I A Theberge, J C Bowdridge, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 10, 2008
D-dimer testing is useful to exclude deep vein thrombosis in elderly outpatients
M Carrier, G Le Gal, S M Bates, et al.
Page
of 36
Search research articles
Search
Showing results (41-50 of 355) with videos related to
Sort By:
Page
of 36
Journal of Thrombosis and Haemostasis : JTH
|
March 9, 2011
Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis
M Carrier, M A Rodger, P S Wells, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 2, 2012
Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients
K Gauthier, M J Kovacs, P S Wells, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 7, 2005
The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients
E Al-Yaseen, P S Wells, J Anderson, et al.
Thrombosis and Haemostasis
|
March 30, 2000
Outpatient treatment of pulmonary embolism with dalteparin
M J Kovacs, D Anderson, B Morrow, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
December 3, 1998
Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis
M Rodger, C Bredeson, P S Wells, et al.
Lancet (London, England)
|
May 21, 1998
SimpliRED D-dimer can reduce the diagnostic tests in suspected deep vein thrombosis
P S Wells, D R Anderson, J Bormanis, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 31, 2009
Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
G Le Gal, M Carrier, S Tierney, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 26, 2010
Incidence and clinical outcomes of occult cancers detected by computed tomographic pulmonary angiography in patients with acute pulmonary embolism
A Y-H Shen, G Le Gal, C Dennie, et al.
Thrombosis Research
|
May 11, 2016
PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease
P S Wells, I A Theberge, J C Bowdridge, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 10, 2008
D-dimer testing is useful to exclude deep vein thrombosis in elderly outpatients
M Carrier, G Le Gal, S M Bates, et al.
Page
of 36